STOCK TITAN

DocuSign director sells $77K in stock under plan

A DocuSign director sold 1,096 shares under a Rule 10b5-1 plan and now holds 3,199 shares.

(Neutral)
(Negative)
Form Type
4

Rhea-AI Filing Summary

DOCUSIGN, INC. (DOCU) director Mary Agnes Wilderotter reported selling 1,096 shares of common stock on September 16, 2026 at $70.60 per share, for about $77,378 in proceeds. The transaction was made under a Rule 10b5-1 trading plan, and she now holds 3,199 shares directly.

Positive

  • None.

Negative

  • None.
Insider Wilderotter Mary Agnes
Role Director
Sold 1,096 shs ($77K)
Type Security Shares Price Value
Sale Common Stock F1 1,096 $70.60 $77K
Holdings After Transaction: Common Stock — 3,199 shares (Direct)
Footnotes (1)
  1. F1. The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
Shares sold 1,096 shares Common stock sale by director on September 16, 2026
Sale price per share $70.60 per share Price for the 1,096 DocuSign shares sold by the director
Estimated transaction value $77,378 Approximate proceeds from sale of 1,096 shares at $70.60
Shares held after transaction 3,199 shares Direct ownership of DocuSign common stock after the reported sale
Trading arrangement Rule 10b5-1 plan Sale executed pursuant to a pre-arranged Rule 10b5-1 plan
Rule 10b5-1 plan regulatory
"The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
Reporting Person regulatory
"The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person"
Common Stock financial
"Common Stock transaction reported for the director of DOCUSIGN, INC."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did DOCU report for Mary Agnes Wilderotter?

Mary Agnes Wilderotter, a director of DocuSign, reported selling 1,096 shares of common stock on September 16, 2026 at a price of $70.60 per share, for total proceeds of roughly $77,378.

Does the DOCU director sale involve a Rule 10b5-1 trading plan?

Yes. The report states that the sale of 1,096 shares by director Mary Agnes Wilderotter was effected pursuant to a Rule 10b5-1 plan adopted by her, indicating the trade was made under a pre-arranged trading arrangement.

How many DOCU shares did Mary Agnes Wilderotter retain after the sale?

After selling 1,096 shares of DocuSign common stock, director Mary Agnes Wilderotter now directly holds 3,199 shares, according to the reported post-transaction ownership figure.

What was the sale price for the DOCU shares sold by the director?

The 1,096 DocuSign shares sold by director Mary Agnes Wilderotter on September 16, 2026 were reported at a price of $70.60 per share, based on the per-share transaction amount disclosed.

Is the DOCU director transaction a purchase or a sale of shares?

The reported transaction by DocuSign director Mary Agnes Wilderotter is a sale of 1,096 shares of common stock, leaving her with 3,199 shares held directly afterward.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wilderotter Mary Agnes

(Last)(First)(Middle)
C/O DOCUSIGN, INC.
221 MAIN STREET, SUITE 800

(Street)
SAN FRANCISCO CALIFORNIA 94105

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
DOCUSIGN, INC. [ DOCU ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/16/2026S1,096(1)D$70.63,199D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
Remarks:
/s/ Lisa Yun, Attorney-in-fact09/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading